SPONSOR
Samsung Medical Center
Total Trials
16
Recruiting
16
Phases
Phase 3, Phase 2, Phase 4
Conditions studied: Atrial Fibrillation (AF)Diseases of the Circulatory SystemAtrial FlutterLymphomaIschemic Heart DiseaseCoronary Artery DiseaseCardiac AmyloidosisCritical IllnessPediatric Intensive Care UnitBreast Cancer
Samsung Medical Center is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter, Lymphoma.
The trial portfolio spans Phase 3, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Samsung Medical Center
How many clinical trials has Samsung Medical Center sponsored?
ClinicalMetric currently tracks 16 clinical trials sponsored by Samsung Medical Center, of which 16 are actively recruiting participants. These trials cover conditions including Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Samsung Medical Center research focus on?
Samsung Medical Center clinical trials span Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter, Lymphoma, Ischemic Heart Disease, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Samsung Medical Center clinical trial?
To participate in a Samsung Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Samsung Medical Center trials with current recruitment status updated daily.
Clinical Trials by Samsung Medical Center
NCT07447297
Recruiting
Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation
Atrial Fibrillation (AF)
NCT07032103
Recruiting
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
Lymphoma
NCT07009418
Recruiting
Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE)
Ischemic Heart Disease
NCT02798705
Recruiting
Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis
Cardiac Amyloidosis
NCT07128446
Recruiting
COPM-Based Goal Setting Strategies in the PICU
Critical Illness
NCT05893966
Recruiting
Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
Breast Cancer
NCT07500701 Phase 3
Recruiting
Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer
Prostate Cancer
NCT07381231 Phase 2
Recruiting
Immunotherapy With Adaptive Pulse Radiotherapy in Solid Tumors
Cancer
NCT07806994
Recruiting
Wearable Eye Tracking During Bimanual Tasks in Children With Cerebral Palsy
Cerebral Palsy (CP)
NCT05812963
Recruiting
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI
ST Elevation Myocardial Infarction
NCT06270238
Recruiting
Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients
Stroke
NCT05444452
Recruiting
GENOSS Coronary Stent Clinical Trial
Ischemic Heart Disease
NCT07121335
Recruiting
SMC Radiation Oncology SABR Cohort for Oligometastasis
Stereotactic Body Radiation Therapy (SBRT)
NCT07559123
Recruiting
Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE
NSCLC
NCT05896865
Recruiting
Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer
Breast Cancer Stage III
NCT07753200 Phase 4
Recruiting
Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease
Atrial Fibrillation (AF)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology